- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/11 - Orthomyxoviridae, e.g. influenza virus
Patent holdings for IPC class C07K 14/11
Total number of patents in this class: 617
10-year publication summary
|
23
|
38
|
42
|
39
|
34
|
36
|
43
|
41
|
23
|
27
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Icahn School of Medicine at Mount Sinai | 1026 |
18 |
| Medicago Inc. | 127 |
18 |
| Sanofi Pasteur Inc. | 282 |
17 |
| Aramis Biotechnologies Inc. | 57 |
17 |
| Janssen Vaccines & Prevention B.V. | 272 |
14 |
| FluGen, Inc. | 38 |
12 |
| Intervet International B.V. | 1343 |
11 |
| Longhorn Vaccines and Diagnostics, LLC | 93 |
11 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3001 |
10 |
| Intervet Inc. | 926 |
9 |
| Duke University | 3182 |
8 |
| AVIR Green Hills Biotechnology Research Development Trade AG | 10 |
6 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3292 |
6 |
| Seqirus Inc. | 257 |
6 |
| The Regents of the University of California | 20694 |
4 |
| Massachusetts Institute of Technology | 10237 |
4 |
| Purdue Research Foundation | 3908 |
4 |
| Academia Sinica | 958 |
4 |
| Folia Biotech Inc. | 10 |
4 |
| Georgia State University Research Foundation, Inc. | 356 |
4 |
| Other owners | 430 |